World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 90 12228 11505 32 31 878 28845

Roberto Giugliani publications per year

The chart shows the history of publications by Roberto Giugliani between 1980 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Roberto Giugliani published across 47 years, from 1980 to 2026, averaging 21.7 papers a year. Output peaked at 69 publications in 2023. 44 of the 1,022 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1980 to 2026. Vertical axis: number of publications, 0 to 69. Peak 69 publications in 2023. 1980: 2 publications 1981: 1 publication 1982: 2 publications 1983: 0 publications 1984: 1 publication 1985: 1 publication 1986: 3 publications 1987: 3 publications 1988: 0 publications 1989: 3 publications 1990: 4 publications 1991: 2 publications 1992: 3 publications 1993: 2 publications 1994: 1 publication 1995: 2 publications 1996: 4 publications 1997: 7 publications 1998: 5 publications 1999: 16 publications 2000: 12 publications 2001: 15 publications 2002: 13 publications 2003: 11 publications 2004: 20 publications 2005: 16 publications 2006: 30 publications 2007: 27 publications 2008: 37 publications 2009: 23 publications 2010: 27 publications 2011: 29 publications 2012: 43 publications 2013: 46 publications 2014: 43 publications 2015: 46 publications 2016: 41 publications 2017: 65 publications 2018: 50 publications 2019: 43 publications 2020: 39 publications 2021: 63 publications 2022: 60 publications 2023: 69 publications 2024: 48 publications 2025: 43 publications 2026: 1 publication
1980 2026

1,022 publications in total across all disciplines

View publications per year as a table
Roberto Giugliani: publications per year, 1980 to 2026
Year Publications
1980 2
1981 1
1982 2
1983 0
1984 1
1985 1
1986 3
1987 3
1988 0
1989 3
1990 4
1991 2
1992 3
1993 2
1994 1
1995 2
1996 4
1997 7
1998 5
1999 16
2000 12
2001 15
2002 13
2003 11
2004 20
2005 16
2006 30
2007 27
2008 37
2009 23
2010 27
2011 29
2012 43
2013 46
2014 43
2015 46
2016 41
2017 65
2018 50
2019 43
2020 39
2021 63
2022 60
2023 69
2024 48
2025 43
2026 1
Total 1,022
Download as CSV

Roberto Giugliani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roberto Giugliani sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 861–880 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 878 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155 878
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Roberto Giugliani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Giugliani sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 90–91 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922 90
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Roberto Giugliani is affiliated with the Federal University of Rio Grande do Sul in Brazil. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, evidenced by their significant publication record. The main areas of study include Physiology, Molecular Biology, Epidemiology, Genetics, and Rheumatology.

The scientist's work extensively covers topics such as Lysosomal Storage Disorders Research, Trypanosoma species research and implications, Glycogen Storage Diseases and Myoclonus, Autoimmune and Inflammatory Disorders Research, Biomedical Research and Pathophysiology, Carbohydrate Chemistry and Synthesis, and Sphingolipid Metabolism and Signaling.

Roberto Giugliani contributes frequently to several scientific journals and has a considerable number of publications in venues including:

  • Molecular Genetics and Metabolism
  • Orphanet Journal of Rare Diseases
  • American Journal of Medical Genetics Part A
  • Molecular Genetics and Metabolism Reports
  • Journal of Inborn Errors of Metabolism and Screening

Notable recent papers by Roberto Giugliani include:

  • "A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results," 2022, Genetics in Medicine
  • "One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency," 2021, Genetics in Medicine
  • "Diagnosis of Mucopolysaccharidoses," 2020, Diagnostics
  • "Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial," 2020, Molecular Genetics and Metabolism
  • "Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B)," 2023, Orphanet Journal of Rare Diseases

Collaborations form an important part of their scientific activity. Frequent co-authors associated with Roberto Giugliani are:

  • Maurizio Scarpa
  • Francyne Kubaski
  • Guilherme Baldo
  • Ana Carolina Brusius-Facchin
  • Paul Harmatz

Roberto Giugliani's extensive work contributes to understanding rare metabolic and genetic disorders through a multidisciplinary approach involving clinical trials, pathology, and molecular studies. The research output reflects ongoing efforts to investigate enzyme replacement therapies and diagnostic methods for lysosomal storage disorders and related diseases.

Best Publications

  • Epidemiology of mucopolysaccharidoses

    Shaukat A. Khan;Hira Peracha;Diana Ballhausen;Alfred Wiesbauer

  • A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

    Joseph Muenzer;James E Wraith;Michael Beck;Roberto Giugliani

  • Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

    Dominique P Germain;Derralynn A Hughes;Kathleen Nicholls;Daniel G Bichet

  • Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)

    Rick Martin;Michael Beck;Christine Eng;Roberto Giugliani

  • Management guidelines for mucopolysaccharidosis VI.

    Roberto Giugliani;Paul Harmatz;James E. Wraith

  • Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    A Mehta;J T R Clarke;R Giugliani;P Elliott

  • Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

    A. Mehta;M. Beck;P. Elliott;R. Giugliani

  • Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.

    Paul Harmatz;Roberto Giugliani;Ida Schwartz;Nathalie Guffon

  • Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

    Elizabeth A. Braunlin;Paul R. Harmatz;Maurizio Scarpa;Beatriz Furlanetto

  • Genetics of homocysteine metabolism and associated disorders.

    S. Brustolin;R. Giugliani;T. M. Félix

  • Multidisciplinary Management of Hunter Syndrome

    Joseph Muenzer;M Beck;C M Eng;M L Escolar

  • Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment

    Giugliani R;Federhen A;Rojas Mv;Vieira T

  • The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families

    Maria Isabel Waddington Achatz;Magali Olivier;Florence Le Calvez;Ghyslaine Martel-Planche

  • Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

    Joseph Muenzer;Michael Beck;Christine M Eng;Roberto Giugliani

  • Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax21Neu +/– mutant mice

    Sarah Porteous;Elena Torban;Nam-Pyo Cho;Heather Cunliffe

  • An international classification of inherited metabolic disorders (ICIMD).

    Carlos R Ferreira;Shamima Rahman;Shamima Rahman;Markus Keller;Johannes Zschocke

  • The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.

    Elfrida R. Benjamin;Maria Cecilia Della Valle;Xiaoyang Wu;Evan Katz

  • Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

    Christian J. Hendriksz;Christian J. Hendriksz;Barbara Burton;Thomas R. Fleming;Paul Harmatz

  • Initial report from the Hunter Outcome Survey.

    J. Edmond Wraith;Michael Beck;Roberto Giugliani;Joe Clarke;Joe Clarke

  • Inborn Errors of Metabolism Sensitivity of Screening Tests in High Risk Patients

    Roberto Giugliani;Carlos S. Dutra-Filho;Maria L. Barth;Janice C. Dutra

Frequent Co-Authors

Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
Shunji Tomatsu
Shunji Tomatsu Alfred I. duPont Hospital for Children
Moacir Wajner
Moacir Wajner Federal University of Rio Grande do Sul
Daniel G. Bichet
Daniel G. Bichet University of Montreal
Yasuyuki Suzuki
Yasuyuki Suzuki Gifu University
Tadao Orii
Tadao Orii Gifu University
Seiji Yamaguchi
Seiji Yamaguchi Shimane University
Simon Jones
Simon Jones Microsoft (United States)
Raphael Schiffmann
Raphael Schiffmann Baylor University
Frits A. Wijburg
Frits A. Wijburg University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a rigorous journey, several alternative online degrees and career pathways can help you enter the healthcare field or complement your medical education. Many students choose online BSN programs for non nurses, which provide a flexible and efficient path to becoming a registered nurse without a prior nursing background.

If you prefer an administrative or non-clinical role, exploring one of the best online medical billing and coding schools can lead to solid career opportunities in healthcare documentation and billing. These programs are often offered entirely online, making them accessible for working adults or career changers.

Prospective nurses concerned about entrance exams should consider schools on the list of do you have to take a teas test for lpn. These schools may offer entry without the common TEAS or HESI test requirements.

For those interested in leadership roles, accredited healthcare administration degree programs can prepare you for management positions in medical facilities, often through accelerated online study formats.

Best Scientists Citing Roberto Giugliani

Trending Scientists

Recently Published Articles